Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

China flag China · Delayed Price · Currency is CNY
5.28
0.00 (0.00%)
At close: Mar 10, 2026
8.42%
Market Cap 7.54B
Revenue (ttm) 6.85B
Net Income (ttm) 374.58M
Shares Out 1.43B
EPS (ttm) 0.27
PE Ratio 19.91
Forward PE n/a
Dividend 0.10 (1.89%)
Ex-Dividend Date Jun 23, 2025
Volume 12,385,618
Average Volume 12,736,546
Open 5.28
Previous Close 5.28
Day's Range 5.25 - 5.31
52-Week Range 4.62 - 6.68
Beta 0.23
RSI 53.06
Earnings Date Apr 3, 2026

About SHE:000597

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products, such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti-infection products, such as fosfomycin series, azithromycin series, amantadine series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost trometham... [Read more]

Sector Healthcare
Founded 1946
Employees 5,964
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000597
Full Company Profile

Financial Performance

In 2024, SHE:000597's revenue was 7.50 billion, a decrease of -8.98% compared to the previous year's 8.24 billion. Earnings were 409.85 million, an increase of 14.34%.

Financial Statements

News

There is no news available yet.